REAKSI SAHAM SEKTOR FARMASI DI BURSA EFEK INDONESIA TERHADAP VAKSINASI COVID-19 PERTAMA PRESIDEN JOKO WIDODO

  • Ni Kadek Sukma Dwiyantika Fakultas Ekonomi dan Bisnis, Universitas Udayana, Bali, Indonesia
  • Gerianta Wirawan Yasa Fakultas Ekonomi dan Bisnis, Universitas Udayana, Bali, Indonesia

Abstract

This study aims to determine the reaction of pharmaceutical sector stocks to President Joko Widodo's first Covid-19 vaccination. The number of samples in this study were 18 companies, the sampling technique used non-probability sampling with saturated sampling method. The data analysis technique used is an event study with a hypothesis testing tool using the One Sample t-Test. The results of this study indicate that there are differences in abnormal returns before and after the administration of President Joko Widodo's first Covid-19 vaccination, where there was a positive reaction before the administration of the first Covid-19 vaccination to President Joko Widodo and a negative reaction at the time of administration on January 13, 2021 and after President Joko Widodo's first Covid-19 vaccination. This shows that it is important for investors to observe critically when absorbing and responding to signals, especially when making investment decisions.

Downloads

Download data is not yet available.
Published
2023-08-31
How to Cite
SUKMA DWIYANTIKA, Ni Kadek; WIRAWAN YASA, Gerianta. REAKSI SAHAM SEKTOR FARMASI DI BURSA EFEK INDONESIA TERHADAP VAKSINASI COVID-19 PERTAMA PRESIDEN JOKO WIDODO. E-Jurnal Ekonomi dan Bisnis Universitas Udayana, [S.l.], p. 1520-1528, aug. 2023. ISSN 2337-3067. Available at: <https://ojs.unud.ac.id/index.php/eeb/article/view/86628>. Date accessed: 21 nov. 2024. doi: https://doi.org/10.24843/EEB.2023.v12.i08.p06.
Section
Articles